创伤团队中的药师:急诊药师参与创伤响应团队的随机对照试验
该非盲随机试验在澳大利亚一家一级创伤中心比较急诊药师参与创伤呼叫与标准治疗,纳入82例需镇痛患者(对照组39例、干预组43例)。药师可按合作药师用药记录模型开具药物。主要终点30分钟内首剂镇痛比例干预组83.7% vs 对照组64.1%(相对风险1.31;95%CI 1.0至1.71;p=0.042)。镇痛时间干预组20(15-26)分钟 vs 对照组28(22-35)分钟;p=0.025。急诊与创伤中心或医院住院时间无差异。
要点
- 干预组30分钟内首剂镇痛36/43(83.7%),对照组25/39(64.1%),相对风险1.31(95%CI 1.0至1.71;p=0.042)。
- 干预组镇痛时间20(15-26)分钟,对照组28(22-35)分钟;p=0.025。
- 药师组38/43(88.4%)患者的首剂镇痛由药师开具,药师还为这些患者开具了27种其他药物。
- 急诊与创伤中心或医院住院时间两组无差异。
- 作者认为急诊药师参与创伤接诊与复苏可能通过优化药物管理提供帮助,使团队成员更专注于其他救命干预。
适用人群与场景
- 在急诊药师工作时间内接受创伤呼叫管理的患者,于澳大利亚一家一级创伤中心纳入。
- 随机化后37例因无需镇痛被排除,最终82例纳入分析(对照组39例、干预组43例)。
处置流程与药物剂量
- 药师按合作药师用药记录模型开具药物。
- 干预组38/43(88.4%)患者的首剂镇痛由药师开具,药师另为这些患者开具27种其他药物用于管理。
研究设计与关键结果
- 非盲随机试验,在澳大利亚一家一级创伤中心比较急诊药师参与创伤呼叫与标准治疗,随机化通过在线单一序列随机化服务完成。
- 2021年7月15日至2022年1月31日共119例患者随机化,37例因无需镇痛排除,82例纳入分析(对照组39例、干预组43例)。
- 主要终点30分钟内首剂镇痛:干预组36/43(83.7%)vs 对照组25/39(64.1%),相对风险1.31(95%CI 1.0至1.71;p=0.042)。
- 镇痛时间:干预组20(15-26)分钟 vs 对照组28(22-35)分钟;p=0.025。
- 干预组38/43(88.4%)患者的首剂镇痛由药师开具;药师另开具27种其他药物。
- 急诊与创伤中心或医院住院时间两组无差异。
证据类型、等级与局限
- 证据类型:非盲随机对照试验。
- 试验注册号:ACTRN12621000338864。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为急诊药师参与创伤接诊与复苏可能通过优化药物管理提供帮助,使团队成员更专注于其他救命干预。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Analgesia is an important component for patient well-being, but commonly delayed during trauma resuscitation. The Pharmacists in Trauma trial assessed the effects of integrating pharmacists into trauma response teams to improve analgesia delivery and medication management.
METHODS: This unblinded randomised trial compared emergency medicine (EM) pharmacist involvement in trauma callouts versus standard care at an Australian level 1 trauma centre. Randomisation was performed via an online single sequence randomisation service. Eligible patients included those managed with a trauma callout during working hours of an EM pharmacist. Pharmacists were able to prescribe medications using a Partnered Pharmacist Medication Charting model. The primary outcome was the proportion of patients who had first dose analgesia within 30 min compared using the χ2 test.
RESULTS: From 15 July 2021 until 31 January 2022, there were 119 patients randomised with 37 patients excluded as no analgesia was required. There were 82 patients included for analysis, 39 in the control arm and 43 in the intervention arm. The primary outcome was achieved in 25 (64.1%) patients in the control arm and 36 (83.7%) patients in the pharmacist arm (relative risk 1.31; 95% CI 1.0 to 1.71; p=0.042). Time to analgesia in the control arm was 28 (22-35) mins and 20 (15-26 mins) with pharmacist involvement; p=0.025. In the pharmacist arm, the initial dose of analgesia was prescribed by the pharmacist for 38 (88.4%) patients. There were 27 other medications prescribed by the pharmacist for the management of these patients. There were no differences in emergency and trauma centre or hospital length of stay.
CONCLUSION: Addition of the EM pharmacist in trauma response teams improved time to analgesia. Involvement of an EM pharmacist in trauma reception and resuscitation may assist by optimising medication management, with members of the team more available to focus on other life-saving interventions.
TRIAL REGISTRATION NUMBER: ACTRN12621000338864.
参考来源
- Roman C, Dooley M, Fitzgerald M, et al. Pharmacists in Trauma: a randomised controlled trial of emergency medicine pharmacists in trauma response teams. Emerg Med J. 2024. PMID: 38749667. doi:10.1136/emermed-2022-212934
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。